Table 3.
Outcome | No. of Women (%) | P a | |
---|---|---|---|
Early Surveillance Group, n = 188 | Traditional Referral Group, n = 285 | ||
Stage of lymphedema | |||
No lymphedema | 142 (76) | 173 (61) | <.001 |
Stage 0 | 19 (10) | 3 (1) | |
Stage I | 19 (10) | 43 (15) | |
Stage II | 8 (4) | 53 (19) | |
Stage III | 0 (0) | 13 (5) |
P values were determined with a nonparametric Wilcoxon rank‐sum test.